A score to quantify coronary plaque vulnerability in high-risk patients with type 2 diabetes: An optical coherence tomography study

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Burgmaier, Mathias ^a   Hellmich, Martin ^b   Marx, Nikolaus ^a   Reith, Sebastian ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Acute coronary syndrome; Optical coherence tomography; Plaque vulnerability; Type 2 diabetes mellitus

Indexed keywords

INSULIN; LIPID; ORAL ANTIDIABETIC AGENT;

ACUTE CORONARY SYNDROME; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY PLAQUE VULNERABILITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INSULIN TREATMENT; LOGISTIC REGRESSION ANALYSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PROBABILITY; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; STABLE ANGINA PECTORIS; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROCEDURES; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AGED; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84906825923     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0117-8     Document Type: Article

References (28)

1. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001, 104(3):365-372. 10.1161/01.CIR.104.3.365, 11457759.
2. Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, Finn AV, Virmani R. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001, 16(5):285-292. 10.1097/00001573-200109000-00006, 11584167.
3. Kubo T, Imanishi T, Kashiwagi M, Ikejima H, Tsujioka H, Kuroi A, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Takarada S, Tanaka A, Mizukoshi M, Akasaka T. Multiple coronary lesion instability in patients with acute myocardial infarction as determined by optical coherence tomography. Am J Cardiol 2010, 105(3):318-322. 10.1016/j.amjcard.2009.09.032, 20102942.
4. Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004, 13(3):125-138. 10.1016/S1054-8807(04)00004-3, 15081469.
5. Reith S, Battermann S, Hoffmann R, Marx N, Burgmaier M. Optical coherence tomography derived differences of plaque characteristics in coronary culprit lesions between type 2 diabetic patients with and without acute coronary syndrome. Catheter Cardiovasc Interv 2013, in press.
6. van Velzen JE, de Graaf FR, Jukema JW, de Grooth GJ, Pundziute G, Kroft LJ, de Roos A, Reiber JH, Bax JJ, Schalij MJ, Schuijf JD, van der Wall EE. Comparison of the relation between the calcium score and plaque characteristics in patients with acute coronary syndrome versus patients with stable coronary artery disease, assessed by computed tomography angiography and virtual histology intravascular ultrasound. Am J Cardiol 2011, 108(5):658-664. 10.1016/j.amjcard.2011.04.009, 21684509.
7. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudek D, Falk E, Feldman MD, Fitzgerald P, Garcia-Garcia HM, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012, 59(12):1058-1072. 10.1016/j.jacc.2011.09.079, 22421299.
8. Tearney GJ, Yabushita H, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Halpern EF, Bouma BE. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation 2003, 107(1):113-119. 10.1161/01.CIR.0000044384.41037.43, 12515752.
9. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339(4):229-234. 10.1056/NEJM199807233390404, 9673301.
10. Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, Mehran R, McPherson J, Farhat N, Marso SP, Parise H, Templin B, White R, Zhang Z, Serruys PW. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011, 364(3):226-235. 10.1056/NEJMoa1002358, 21247313.
11. Reith S, Battermann S, Jaskolka A, Lehmacher W, Hoffmann R, Marx N, Burgmaier M. Predictors and incidence of stent edge dissections in patients with type 2 diabetes as determined by optical coherence tomography. Int J Cardiovasc Imaging 2013, 29(6):1237-1247. 10.1007/s10554-013-0213-y, 23558468.
12. Reith S, Battermann S, Jaskolka A, Lehmacher W, Hoffmann R, Marx N, Burgmaier M. Relationship between optical coherence tomography derived intraluminal and intramural criteria and haemodynamic relevance as determined by fractional flow reserve in intermediate coronary stenoses of patients with type 2 diabetes. Heart 2013, 99(10):700-707. 10.1136/heartjnl-2013-303616, 23543283.
13. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, Shishkov M, Houser S, Aretz HT, Halpern EF, Bouma BE. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005, 111(12):1551-1555. 10.1161/01.CIR.0000159354.43778.69, 15781733.
14. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988, 240(4857):1285-1293. 10.1126/science.3287615, 3287615.
15. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006, 47(8 Suppl):C13-C18. 10.1016/j.jacc.2005.10.065, 16631505.
16. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000, 20(5):1262-1275. 10.1161/01.ATV.20.5.1262, 10807742.
17. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 2003, 108(14):1664-1672. 10.1161/01.CIR.0000087480.94275.97, 14530185.
18. Manoharan G, Ntalianis A, Muller O, Hamilos M, Sarno G, Melikian N, Vanderheyden M, Heyndrickx GR, Wyffels E, Wijns W, De Bruyne B. Severity of coronary arterial stenoses responsible for acute coronary syndromes. Am J Cardiol 2009, 103(9):1183-1188. 10.1016/j.amjcard.2008.12.047, 19406256.
19. Tian J, Ren X, Vergallo R, Xing L, Yu H, Jia H, Soeda T, McNulty I, Hu S, Lee H, Yu B, Jang IK. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol 2014, 63(21):2209-2216. 10.1016/j.jacc.2014.01.061, 24632266.
20. Frobert O, van't Veer M, Aarnoudse W, Simonsen U, Koolen JJ, Pijls NH. Acute myocardial infarction and underlying stenosis severity. Catheter Cardiovasc Interv 2007, 70(7):958-965. 10.1002/ccd.21280, 17621673.
21. Cheng JM, Garcia-Garcia HM, de Boer SP, Kardys I, Heo JH, Akkerhuis KM, Oemrawsingh RM, van Domburg RT, Ligthart J, Witberg KT, Regar E, Serruys PW, van Geuns RJ, Boersma E. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J 2014, 35(10):639-647. 10.1093/eurheartj/eht484, 24255128.
22. Mancini GB, Hartigan PM, Shaw LJ, Berman DS, Hayes SW, Bates ER, Maron DJ, Teo K, Sedlis SP, Chaitman BR, Weintraub WS, Spertus JA, Kostuk WJ, Dada M, Booth DC, Boden WE. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. JACC Cardiovasc Interv 2014, 7(2):195-201. 10.1016/j.jcin.2013.10.017, 24440015.
23. Shemesh J, Tenenbaum A, Fisman EZ, Koren-Morag N, Grossman E. Coronary calcium in patients with and without diabetes: first manifestation of acute or chronic coronary events is characterized by different calcification patterns. Cardiovasc Diabetol 2013, 12(1):161. 10.1186/1475-2840-12-161, 24188692.
24. Burgmaier M, Frick M, Liberman A, Battermann S, Hellmich M, Lehmacher W, Jaskolka A, Marx N, Reith S. Plaque vulnerability of coronary artery lesions is related to left ventricular dilatation as determined by optical coherence tomography and cardiac magnetic resonance imaging in patients with type 2 diabetes. Cardiovasc Diabetol 2013, 12(1):102. 10.1186/1475-2840-12-102, 23844855.
25. Park JP, Lee BK, Shim JM, Kim SH, Lee CW, Kang DH, Hong MK. Relationship between multiple plasma biomarkers and vulnerable plaque determined by virtual histology intravascular ultrasound. Circ J 2010, 74(2):332-336. 10.1253/circj.CJ-09-0570, 20009356.
26. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging 2012, 5(4):433-440. 10.1161/CIRCIMAGING.112.973701, 22679059.
27. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, Van't Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009, 360(3):213-224. 10.1056/NEJMoa0807611, 19144937.
28. Sels JW, Tonino PA, Siebert U, Fearon WF, Van't Veer M, De Bruyne B, Pijls NH. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. JACC Cardiovasc Interv 2011, 4(11):1183-1189. 10.1016/j.jcin.2011.08.008, 22115657.